(Q34274253)

1 August 2017

1 reference

title

Treatment of typical absence seizures and related epileptic syndromes (English)

1 reference

1 August 2017

Panayiotopoulos CP

1

1 reference

1 August 2017

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

3

1 reference

1 August 2017

5

1 reference

1 August 2017

379-403

1 reference

https://scigraph.springernature.com/pub.10.2165/00128072-200103050-00006

1 August 2017

0 references

cites work

Effect of valproic acid on spike and wave discharges in patients with absence seizures

1 reference

https://api.crossref.org/works/10.2165%2F00128072-200103050-00006

Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00128072-200103050-00006

Serum clonazepam concentrations in children with absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00128072-200103050-00006

Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00128072-200103050-00006

21 January 2018

1 reference

12 December 2020

Clinical and genetic analysis of a large pedigree with juvenile myoclonic epilepsy.

1 reference

12 December 2020

Efficacy of lamotrigine (LTG) monotherapy

1 reference

12 December 2020

Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)

1 reference

12 December 2020

On the association between valproate and polycystic ovary syndrome: a response and an alternative view

1 reference

12 December 2020

Subependymal heterotopia: a distinct neuronal migration disorder associated with epilepsy

1 reference

12 December 2020

Diamox in epilepsy. A critical review of 178 case

1 reference

12 December 2020

Computer model of ethosuximide's effect on a thalamic neuron

1 reference

12 December 2020

Inappropriate use of carbamazepine and vigabatrin in typical absence seizures

1 reference

12 December 2020

Clinical experience with lamotrigine monotherapy in adults with newly diagnosed epilepsy: a review of published randomised clinical trials

1 reference

12 December 2020

Seizures with clonazepam: discontinuation and suggestions for safe discontinuation rates in children

1 reference

12 December 2020

Incidence of Epilepsy in Children: A Follow-up Study Three Years After the First Seizure

1 reference

12 December 2020

Evaluation of treatment in typical absence seizures. The roles of long-term EEG monitoring and ethosuximide

1 reference

12 December 2020

Clinical and EEG response to clonazepam in four patients with self-induced photosensitive epilepsy

1 reference

12 December 2020

Idiopathic generalised epilepsy in adults manifested by phantom absences, generalised tonic-clonic seizures, and frequent absence status

1 reference

12 December 2020

Typical absence seizures and their treatment

1 reference

12 December 2020

Lamotrigine: a review of antiepileptic efficacy

1 reference

12 December 2020

Lamotrigine in absence and primary generalized epilepsies

1 reference

12 December 2020

[Course forms of infantile epilepsies with spike waves absences]

1 reference

12 December 2020

Antiepileptic drug mechanisms of action

1 reference

12 December 2020

Dramatic effect of ethosuximide on epileptic negative myoclonus: implications for the neurophysiological mechanism.

1 reference

12 December 2020

Interaction of lamotrigine with sodium valproate

1 reference

12 December 2020

Ethosuximide in the treatment of absence (peptit mal) seizures

1 reference

12 December 2020

Familial occurrence of epilepsy in children with newly diagnosed multiple seizures: Dutch Study of Epilepsy in Childhood

1 reference

12 December 2020

Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy

1 reference

12 December 2020

Epilepsy with myoclonic absences

1 reference

12 December 2020

No evidence for a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q

1 reference

12 December 2020

Sodium valproate: monotherapy and polytherapy

1 reference

12 December 2020

Exacerbation of seizures in children by carbamazepine

1 reference

12 December 2020

Absence status and the concurrent administration of clonazepam and valproate sodium

1 reference

12 December 2020

Valproate prevents the recurrence of absence status

1 reference

12 December 2020

The outcome of absence epilepsy: a meta-analysis.

1 reference

12 December 2020

Treatment of epileptic falling spells with ethosuximide.

1 reference

12 December 2020

Is valproate pharmacotherapy associated with polycystic ovaries?

1 reference

12 December 2020

Juvenile myoclonic epilepsy: a 5-year prospective study.

1 reference

12 December 2020

On the association between valproate and polycystic ovary syndrome

1 reference

12 December 2020

Juvenile myoclonic epilepsy. A review

1 reference

12 December 2020

Epilepsies in twins: genetics of the major epilepsy syndromes.

1 reference

12 December 2020

Absence seizures and carbamazepine in adults

1 reference

12 December 2020

Treatment of epilepsy with clonazepam and its effect on other anticonvulsants

1 reference

12 December 2020

Positron emission tomography receptor studies

1 reference

12 December 2020

Studies of the lethargic (lh/lh) mouse model of absence seizures: regulatory mechanisms and identification of the lh gene.

1 reference

12 December 2020

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

12 December 2020

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

12 December 2020

Potential hepatotoxicity of lamotrigine

1 reference

12 December 2020

Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)

1 reference

12 December 2020

Valproic acid versus ethosuximide in the treatment of absence seizures

1 reference

12 December 2020

Lamotrigine monotherapy in children

1 reference

12 December 2020

Double-Blind, Placebo-Controlled, Lamotrigine in Treatment-Resistant Generalised Epilepsy

1 reference

12 December 2020

The significance of microdysgenesia in primary generalized epilepsy: an answer to the considerations of Lyon and Gastaut.

1 reference

12 December 2020

Lamotrigine in the treatment of absence seizures

1 reference

12 December 2020

Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q.

1 reference

12 December 2020

Clonazepam in juvenile myoclonic epilepsy

1 reference

12 December 2020

Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

1 reference

12 December 2020

Tiagabine and non-convulsive status epilepticus

1 reference

12 December 2020

Valproic acid in the treatment of intractable absence seizures in children: a single-blind clinical and quantitative EEG study

1 reference

12 December 2020

Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy

1 reference

12 December 2020

Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide

1 reference

12 December 2020

Lamotrigine. A review of its use in childhood epilepsy

1 reference

12 December 2020

Genetics of inherited epilepsies

1 reference

12 December 2020

Disabling tremor after lamotrigine with sodium valproate

1 reference

12 December 2020

Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4-Hz spike and multispike-slow wave complexes: linkage to chromosome 8q24.

1 reference

12 December 2020

Mechanisms of generalized absence epilepsy

1 reference

12 December 2020

Hematologic toxicity of sodium valproate

1 reference

12 December 2020

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

1 reference

12 December 2020

Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years.

1 reference

12 December 2020

Will a critical level of hyperventilation-induced hypocapnia always induce an absence seizure?

1 reference

12 December 2020

Prognostic factors for childhood and juvenile absence epilepsies.

1 reference

12 December 2020

Perioral myoclonia with absences? A case report with EEG and voltage mapping analysis.

1 reference

12 December 2020

Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat

1 reference

12 December 2020

Evidence for linkage of adolescent-onset idiopathic generalized epilepsies to chromosome 8-and genetic heterogeneity

1 reference

12 December 2020

Abnormal cerebral structure in juvenile myoclonic epilepsy demonstrated with voxel-based analysis of MRI

1 reference

12 December 2020

Vigabatrin aggravates absences and absence status

1 reference

12 December 2020

Eyelid myoclonia with absences in adults: a clinical and video-EEG study.

1 reference

12 December 2020

Epidemiology of absence epilepsy. I. Concept and incidence.

1 reference

12 December 2020

Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.

1 reference

12 December 2020

A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.

1 reference

12 December 2020

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

1 reference

12 December 2020

Clinical and genetic aspects of juvenile absence epilepsy

1 reference

12 December 2020

Valproic acid and ethosuximide interaction

1 reference

12 December 2020

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

12 December 2020

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

1 reference

12 December 2020

GABAA receptor function in developing rat thalamic reticular neurons: whole cell recordings of GABA-mediated currents and modulation by clonazepam

1 reference

12 December 2020

Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.

1 reference

12 December 2020

Pathophysiological mechanisms of genetic absence epilepsy in the rat.

1 reference

12 December 2020

Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement.

1 reference

12 December 2020

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

1 reference

12 December 2020

Absence epilepsy of early childhood--genetic aspects

1 reference

12 December 2020

Beneficial effect of relatively small doses of lamotrigine.

1 reference

12 December 2020

[Functional imaging in idiopathic generalized epilepsy]

1 reference

12 December 2020

Lamotrigine-associated rash: risk/benefit considerations in adults and children

1 reference

12 December 2020

Absences in juvenile myoclonic epilepsy: a clinical and video-electroencephalographic study

1 reference

12 December 2020

Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures

1 reference

12 December 2020

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

1 reference

12 December 2020

Mechanisms of action of valproate: a commentatory

1 reference

12 December 2020

Typical absence status in adults: diagnostic and syndromic considerations

1 reference

12 December 2020

A Long‐term Follow‐up of Acetazolamide (Diamox) in the Treatment of Epilepsy

1 reference

12 December 2020

Valproate and the polycystic ovarian syndrome: final thoughts

1 reference

12 December 2020

Effects of lamotrigine on absence seizures in rats

1 reference

12 December 2020

Lamotrigine in typical absence epilepsy.

1 reference

12 December 2020

Consistent EEG focalities detected in subjects with primary generalized epilepsies monitored for two decades.

1 reference

12 December 2020

Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics

1 reference

12 December 2020

1 reference

12 December 2020

Lupus anticoagulant induced by the combination of valproate and lamotrigine

1 reference

12 December 2020

Importance of specifying the type of epilepsy

1 reference

12 December 2020

Quantitative MRI in patients with idiopathic generalized epilepsy. Evidence of widespread cerebral structural changes.

1 reference

12 December 2020

Survey of seizure disorders in the French southwest. I. Incidence of epileptic syndromes

1 reference

12 December 2020

Benzodiazepines in the treatment of epilepsy. A review

1 reference

12 December 2020

Lamotrigine for the treatment of epilepsy in childhood

1 reference

12 December 2020

Valproate and clonazepam comedication in patients with intractable epilepsy

1 reference

12 December 2020

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

1 reference

12 December 2020

Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in?

1 reference

12 December 2020

Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.

1 reference

12 December 2020

Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy

1 reference

12 December 2020

Generalized epilepsies: emerging insights into cellular and genetic mechanisms.

1 reference

12 December 2020

The use of lamotrigine in juvenile myoclonic epilepsy

1 reference

12 December 2020

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

12 December 2020

Lamotrigine as an add-on drug in typical absence seizures

1 reference

12 December 2020

Sodium valproate acutely inhibits lamotrigine metabolism

1 reference

12 December 2020

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

1 reference

12 December 2020

Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group

1 reference

12 December 2020

Clonazepam in the treatment of epilepsy

1 reference

12 December 2020

Typical absence seizures in adults: clinical, EEG, video-EEG findings and diagnostic/syndromic considerations

1 reference

12 December 2020

Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy.

1 reference

12 December 2020

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

12 December 2020

Differentiation of typical absence seizures in epileptic syndromes. A video EEG study of 224 seizures in 20 patients.

1 reference

12 December 2020

Mapping and positional cloning of common idiopathic generalized epilepsies: juvenile myoclonus epilepsy and childhood absence epilepsy.

1 reference

12 December 2020

Clinical Experience with Clonazepam (Rivotril) in the Treatment of Epilepsies in Infancy and Childhood

1 reference

12 December 2020

10.2165/00128072-200103050-00006

Identifiers

DOI

1 reference

PubMed ID

11393330

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11393330